Skip to content

Evaluation of Marketed Contact Lens Disinfectant Systems on Eyelid Tissues

Evaluation of the Effects of Clear Care/AOSEPT Plus Hydrogen Peroxide Solution on the Eyelid Tissues - Part II: Comparative Evaluation With RENU MPS Over 3 Months of Wear

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01494818
Enrollment
79
Registered
2011-12-19
Start date
2011-11-30
Completion date
2012-07-31
Last updated
2013-09-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contact Lens Care

Keywords

Contact lenses, Contact lens solutions

Brief summary

The purpose of this study was to assess and compare the effect of the repeated usage of two different contact lens care systems (one hydrogen peroxide-based cleaning and disinfecting system, and one polyaminopropyl biguanide (PHMB)-containing multipurpose system) with silicone hydrogel contact lenses worn on a daily wear basis for three months. The specific aspect of interest was the effect on the ocular tissue, in particular the eyelids and their associations with the contact lens surface wettability and surface contamination.

Detailed description

The subjects attended the enrollment visit having worn their habitual silicone hydrogel contact lenses for at least six hours on the day of the visit. The enrollment visit was scheduled so that the subjects' habitual lenses were at least 14 ± 3 days old for the subjects replacing their lenses bi-weekly and at least 30 ± 5 days old for those replacing their lenses monthly.

Interventions

DEVICEHydrogen peroxide-based contact lens care system
DEVICEPHMB-containing contact lens solution

Contact lenses identical to habitual prescription worn per usual replacement regimen

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Read and understand Participant Information Sheet; * Read, sign, and date Informed Consent; * Successfully wearing silicone hydrogel contact lenses under a frequent replacement (biweekly or monthly) daily wear modality; * Using a PHMB-containing multipurpose contact lens solution; * Symptomatic, as specified in protocol; * Best corrected visual acuity of 6/9 or better in each eye; * Other protocol-defined inclusion criteria may apply.

Exclusion criteria

* Any known sensitivity or intolerance to the contact lenses or len care products to be used; * Systemic disease/medication which might interfere with contact lens wear or produce dry eye side effects; * Ocular allergies or ocular disease which might interfere with contact lens wear; * Use of any concomitant topical ocular medications during the study period; * Participation in an investigational drug or device study within 30 days of entering the study; * Other protocol-defined

Design outcomes

Primary

MeasureTime frameDescription
Change From Baseline in Upper Eyelid Margin Staining at Month 3Baseline, Month 3The contact lens was removed and ophthalmic dye was instilled. Upper eyelid margin staining was objectively measured through digital images. The extent of true staining (i.e., the total area of lid margin covered by staining) was recorded. Both eyes were included in the model for analysis.
Maximum PapillaeBaseline, Month 3Eyelid papillae (bumps on the inner eyelid) were recorded separately for three zones of the upper lid and overall for the lower lid on a 5-point forced choice scale (0 = None; 1 = Slight (diffuse papillae); 2 = Mild (diffuse & tufts papillae); 3 = Moderate (moderate & tufts papillae); 4 = Severe (giant papillae). The maximum value represents the worse grade in any zone. Both eyes were included in the model for analysis.
Maximum Eyelid HyperaemiaBaseline, Month 3Eyelid hyperaemia (redness) was recorded separately for three zones of the upper lid and overall for the lower lid on a 5-point forced choice scale (0 = Clear; 1 = Slight redness; 2 = Mild redness; 3 = Moderate redness; 4 = Severe redness). The maximum value represents the worst grade in any zone. Both eyes were included in the model for analysis.
Upper Lid RednessBaseline, Month 3The contact lenses were removed and upper lid redness was objectively measured through digital images. The coverage of the palpebral surface by blood vessels is expressed as percentage of the total surface measured. Both eyes were included in the model for analysis.

Secondary

MeasureTime frameDescription
Median Non-Invasive Pre-Lens Tear Film Break Up Time (PL-NIBUT)Baseline, Month 3The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eyelid and the contact lens). The time required for a dry spot to appear on the pre-lens surface after blinking is referred to as the pre-lens tear film break up time. PL-NIBUT was evaluated using a biomicroscope with a diffuse illumination source, i.e., Tearscope. A longer PL-NIBUT indicates a more stable tear film and greater on-eye lens wettability. Three PL-NIBUT measurements were recorded, and the median value was used for analysis. Both eyes were included in the model for analysis.
Protective IndexBaseline, Month 3A digital video recording was made of the interblink period. The percentage of area of the visible contact lens covered by the tear film was calculated (Protected Area). The Protective Index is defined as the average tear coverage over the whole interblink period. Both eyes were included in the model for analysis.
Median Front Lens DepositsBaseline, Month 3Deposits present on the front surface of the lens were assessed with a biomicroscope while the lens was on eye. Deposits were rated on a 5-point forced choice scale (0 = none; 1 = slight; = mild; 3 = moderate; 4 = severe) in five lens zones. The median of the five zones was used for analysis. Both eyes were included in the model for analysis.
Total Lipid Uptake Per LensBaseline, Month 3The contact lens was aseptically removed from the eye. Lipids were extracted and analyzed using a proprietary High Performance Liquid Chromatography technique. A lower value would indicate a cleaner lens surface.

Participant flow

Recruitment details

Participants were recruited from one study center located in the United Kingdom.

Pre-assignment details

Of the 79 participants enrolled in the study, 1 participant exited the study between enrollment and product dispensing due to nonavailability. This reporting group includes all enrolled and dispensed participants.

Participants by arm

ArmCount
CLEAR CARE/AOSEPT Plus
Hydrogen peroxide-based contact lens care system used with silicone hydrogel contact lenses per manufacturer's instructions for 3 months
37
ReNu MultiPlus
PHMB-containing contact lens solution used with silicone hydrogel contact lenses per manufacturer's instructions for 3 months
37
Total74

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up10
Overall StudyRelocation12

Baseline characteristics

CharacteristicCLEAR CARE/AOSEPT PlusReNu MultiPlusTotal
Age Continuous34.8 years
STANDARD_DEVIATION 9.8
35.5 years
STANDARD_DEVIATION 10.5
35.1 years
STANDARD_DEVIATION 10.1
Sex: Female, Male
Female
21 Participants25 Participants46 Participants
Sex: Female, Male
Male
16 Participants12 Participants28 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 390 / 39
serious
Total, serious adverse events
2 / 390 / 39

Outcome results

Primary

Change From Baseline in Upper Eyelid Margin Staining at Month 3

The contact lens was removed and ophthalmic dye was instilled. Upper eyelid margin staining was objectively measured through digital images. The extent of true staining (i.e., the total area of lid margin covered by staining) was recorded. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureValue (MEAN)Dispersion
CLEAR CARE/AOSEPT PlusChange From Baseline in Upper Eyelid Margin Staining at Month 3-0.014 square millimetersStandard Deviation 3.905
ReNu MultiPlusChange From Baseline in Upper Eyelid Margin Staining at Month 3-0.754 square millimetersStandard Deviation 4.179
Primary

Maximum Eyelid Hyperaemia

Eyelid hyperaemia (redness) was recorded separately for three zones of the upper lid and overall for the lower lid on a 5-point forced choice scale (0 = Clear; 1 = Slight redness; 2 = Mild redness; 3 = Moderate redness; 4 = Severe redness). The maximum value represents the worst grade in any zone. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEDIAN)
CLEAR CARE/AOSEPT PlusMaximum Eyelid HyperaemiaBaseline (habitual contact lenses and care system)2.0 Units on a scale
CLEAR CARE/AOSEPT PlusMaximum Eyelid HyperaemiaMonth 32.0 Units on a scale
ReNu MultiPlusMaximum Eyelid HyperaemiaBaseline (habitual contact lenses and care system)2.0 Units on a scale
ReNu MultiPlusMaximum Eyelid HyperaemiaMonth 32.0 Units on a scale
Primary

Maximum Papillae

Eyelid papillae (bumps on the inner eyelid) were recorded separately for three zones of the upper lid and overall for the lower lid on a 5-point forced choice scale (0 = None; 1 = Slight (diffuse papillae); 2 = Mild (diffuse & tufts papillae); 3 = Moderate (moderate & tufts papillae); 4 = Severe (giant papillae). The maximum value represents the worse grade in any zone. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEDIAN)
CLEAR CARE/AOSEPT PlusMaximum PapillaeBaseline (habitual contact lenses and care system)2.0 Units on a scale
CLEAR CARE/AOSEPT PlusMaximum PapillaeMonth 32.0 Units on a scale
ReNu MultiPlusMaximum PapillaeBaseline (habitual contact lenses and care system)2.0 Units on a scale
ReNu MultiPlusMaximum PapillaeMonth 32.0 Units on a scale
Primary

Upper Lid Redness

The contact lenses were removed and upper lid redness was objectively measured through digital images. The coverage of the palpebral surface by blood vessels is expressed as percentage of the total surface measured. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEAN)Dispersion
CLEAR CARE/AOSEPT PlusUpper Lid RednessBaseline (habitual contact lenses and care system)34.8 Percentage of total surface measuredStandard Deviation 6.8
CLEAR CARE/AOSEPT PlusUpper Lid RednessMonth 335.2 Percentage of total surface measuredStandard Deviation 7
ReNu MultiPlusUpper Lid RednessBaseline (habitual contact lenses and care system)34.9 Percentage of total surface measuredStandard Deviation 6.1
ReNu MultiPlusUpper Lid RednessMonth 335.4 Percentage of total surface measuredStandard Deviation 5.8
Secondary

Median Front Lens Deposits

Deposits present on the front surface of the lens were assessed with a biomicroscope while the lens was on eye. Deposits were rated on a 5-point forced choice scale (0 = none; 1 = slight; = mild; 3 = moderate; 4 = severe) in five lens zones. The median of the five zones was used for analysis. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEDIAN)
CLEAR CARE/AOSEPT PlusMedian Front Lens DepositsBaseline (habitual contact lenses and care system)0 Units on a scale
CLEAR CARE/AOSEPT PlusMedian Front Lens DepositsMonth 30 Units on a scale
ReNu MultiPlusMedian Front Lens DepositsBaseline (habitual contact lenses and care system)0 Units on a scale
ReNu MultiPlusMedian Front Lens DepositsMonth 30 Units on a scale
Secondary

Median Non-Invasive Pre-Lens Tear Film Break Up Time (PL-NIBUT)

The pre-lens tear film is the layer of tears located on top of the contact lens (i.e., between the eyelid and the contact lens). The time required for a dry spot to appear on the pre-lens surface after blinking is referred to as the pre-lens tear film break up time. PL-NIBUT was evaluated using a biomicroscope with a diffuse illumination source, i.e., Tearscope. A longer PL-NIBUT indicates a more stable tear film and greater on-eye lens wettability. Three PL-NIBUT measurements were recorded, and the median value was used for analysis. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEAN)Dispersion
CLEAR CARE/AOSEPT PlusMedian Non-Invasive Pre-Lens Tear Film Break Up Time (PL-NIBUT)Baseline (habitual contact lenses and care system)4.05 SecondsStandard Deviation 4.63
CLEAR CARE/AOSEPT PlusMedian Non-Invasive Pre-Lens Tear Film Break Up Time (PL-NIBUT)Month 35.76 SecondsStandard Deviation 4.5
ReNu MultiPlusMedian Non-Invasive Pre-Lens Tear Film Break Up Time (PL-NIBUT)Baseline (habitual contact lenses and care system)5.08 SecondsStandard Deviation 4.07
ReNu MultiPlusMedian Non-Invasive Pre-Lens Tear Film Break Up Time (PL-NIBUT)Month 34.22 SecondsStandard Deviation 2.12
Secondary

Protective Index

A digital video recording was made of the interblink period. The percentage of area of the visible contact lens covered by the tear film was calculated (Protected Area). The Protective Index is defined as the average tear coverage over the whole interblink period. Both eyes were included in the model for analysis.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEAN)Dispersion
CLEAR CARE/AOSEPT PlusProtective IndexBaseline (habitual contact lenses and care system)95.9 Percent of visible contact lens surfaceStandard Deviation 11
CLEAR CARE/AOSEPT PlusProtective IndexMonth 396.4 Percent of visible contact lens surfaceStandard Deviation 10
ReNu MultiPlusProtective IndexBaseline (habitual contact lenses and care system)95.8 Percent of visible contact lens surfaceStandard Deviation 10.2
ReNu MultiPlusProtective IndexMonth 397.8 Percent of visible contact lens surfaceStandard Deviation 5.8
Secondary

Total Lipid Uptake Per Lens

The contact lens was aseptically removed from the eye. Lipids were extracted and analyzed using a proprietary High Performance Liquid Chromatography technique. A lower value would indicate a cleaner lens surface.

Time frame: Baseline, Month 3

Population: All enrolled and dispensed participants who completed the study as per protocol

ArmMeasureGroupValue (MEAN)Dispersion
CLEAR CARE/AOSEPT PlusTotal Lipid Uptake Per LensBaseline (habitual contact lenses and care system)38.95 microgramsStandard Deviation 23.94
CLEAR CARE/AOSEPT PlusTotal Lipid Uptake Per LensMonth 332.40 microgramsStandard Deviation 24.53
ReNu MultiPlusTotal Lipid Uptake Per LensBaseline (habitual contact lenses and care system)36.44 microgramsStandard Deviation 47.59
ReNu MultiPlusTotal Lipid Uptake Per LensMonth 334.20 microgramsStandard Deviation 26.57

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026